PharmaVoice: Getting IND ready — how companies can avoid common traps

Celebrating 60 inspirational individuals – across small molecules, biopharma, and cell and gene therapy – who are helping to translate pharma’s...

Patient apheresis heterogeneity from prior systemic therapy, collection settings, anticoagulants, timing, and transport/cryopreservation cannot be...

Read the perspectives of industry experts here: Pharma's Almanac